Doxycycline covers an unusually wide range of infections for a single antibiotic. It works against many gram-positive and gram-negative bacteria, atypical organisms like chlamydia and mycoplasma, tick-borne diseases, certain parasites, and even some uses that have nothing to do with killing bacteria at all. This broad coverage is why it shows up in treatment plans for everything from acne to anthrax.
Gram-Positive and Gram-Negative Bacteria
Doxycycline belongs to the tetracycline family, and like other tetracyclines, it disrupts the way bacteria build proteins, effectively stopping them from multiplying. Its spectrum includes bacteria on both sides of the major classification divide.
On the gram-negative side, doxycycline reliably covers the bacteria responsible for cholera, plague, tularemia (rabbit fever), and certain sexually transmitted infections including gonorrhea (though resistance is a growing concern). It also covers Brucella species, which cause undulant fever from contact with livestock.
On the gram-positive side, coverage is less predictable. Up to 44% of group A strep strains and 74% of enterococcal strains have shown resistance to tetracyclines in FDA labeling data. That means doxycycline is not a go-to choice for strep throat or enterococcal infections unless lab testing confirms the specific strain is susceptible. For staph infections, including MRSA skin infections, doxycycline is sometimes used, though resistance can develop, particularly in people who take doxycycline long-term for other reasons like malaria prevention.
Atypical Bacteria
This is one of doxycycline’s most important roles. “Atypical” bacteria are organisms that don’t respond to standard antibiotics like penicillin or amoxicillin. Doxycycline covers three major groups:
- Chlamydia species: This includes the sexually transmitted Chlamydia trachomatis and the respiratory pathogen Chlamydophila pneumoniae.
- Mycoplasma pneumoniae: A common cause of “walking pneumonia,” especially in younger adults. In the U.S. and Europe, about 10% of strains are resistant to the macrolide antibiotics often used first, making doxycycline an important backup. In parts of Asia, macrolide resistance runs as high as 80%, which elevates doxycycline’s role further.
- Rickettsia species: These cause Rocky Mountain spotted fever, typhus, and other tick-borne or flea-borne infections. Doxycycline is the treatment of choice for virtually all rickettsial diseases.
Current pneumonia guidelines recommend doxycycline (alongside macrolides) as a first-line option for uncomplicated community-acquired pneumonia specifically because it covers these atypical organisms that standard antibiotics miss.
Tick-Borne Diseases
Doxycycline is the backbone antibiotic for tick-borne infections in the United States. It covers Lyme disease, Rocky Mountain spotted fever, ehrlichiosis, and anaplasmosis. For suspected Rocky Mountain spotted fever, treatment with doxycycline should start immediately based on symptoms alone, without waiting for lab confirmation, because delays can be fatal.
For Lyme disease prevention after a tick bite, a single 200 mg dose of doxycycline can reduce the risk of infection if certain criteria are met: the tick was a blacklegged (deer) tick, it was removed within 72 hours, and the bite occurred in an area where Lyme-carrying ticks are common. The key detail is that prophylaxis works best within that 72-hour window after tick removal, since the Lyme bacterium needs at least three days to transmit after a bite. Active Lyme disease requires a longer treatment course.
The American Academy of Pediatrics confirmed in 2018 that doxycycline is safe in children of all ages for courses of three weeks or less. This matters because tick-borne diseases are common in children, and for decades many doctors avoided prescribing doxycycline to kids under eight out of concern for tooth staining. Short courses do not carry that risk.
Sexually Transmitted Infections
Doxycycline is a standard treatment for chlamydia and is also used for syphilis in patients who can’t tolerate the preferred penicillin-based treatment. It covers lymphogranuloma venereum (caused by specific chlamydia strains) and granuloma inguinale as well.
More recently, doxycycline has gained attention as a post-exposure prophylaxis for STIs, taken after unprotected sex to prevent chlamydia and syphilis. This approach is effective but has raised concerns about driving antibiotic resistance, particularly in staph bacteria that colonize the skin and in Mycoplasma genitalium, where early signs of resistance mutations have already been identified.
Malaria Prevention
Doxycycline is one of the main options for preventing malaria during travel to endemic areas. The regimen is 100 mg once daily, starting one to two days before entering a malaria zone and continuing for four weeks after leaving. That four-week tail is important because the malaria parasite can linger in the bloodstream after exposure, and stopping early leaves you vulnerable.
Compared to other malaria prevention drugs, doxycycline is inexpensive and widely available. The tradeoffs are the daily dosing (some alternatives are weekly) and the potential for sun sensitivity, which matters in tropical destinations.
Anthrax Exposure
In a bioterrorism or occupational exposure scenario, doxycycline is a frontline option for preventing anthrax infection. The CDC recommends 100 mg twice daily, taken 12 hours apart, for adults and children over 76 pounds. Treatment typically starts with a 10-day supply but may extend up to 60 days depending on the nature and duration of the exposure. Children under 76 pounds receive a weight-based liquid formulation on the same schedule.
Skin Conditions: Acne and Rosacea
Doxycycline treats moderate to severe acne at standard antibiotic doses, typically prescribed for several months. But it also has anti-inflammatory properties that work independently of its ability to kill bacteria. For rosacea, a sub-antimicrobial dose of 20 mg twice daily reduces the facial redness and bumps of rosacea without acting as an antibiotic at all. At this low dose, studies show no detectable antibiotic activity, which means it doesn’t contribute to resistance. This makes it one of the few antibiotics prescribed long-term where resistance isn’t a primary concern.
What Doxycycline Does Not Cover Well
Doxycycline has gaps. It is not reliable against Pseudomonas aeruginosa, a common cause of hospital-acquired infections. Many strains of E. coli, Klebsiella, and other common gut bacteria have developed resistance, so it’s not a first choice for urinary tract infections or abdominal infections. Strep and enterococcal infections require susceptibility testing before doxycycline would be considered. And while it works against many staph strains, resistance can emerge during prolonged use.
Absorption and Timing
One practical detail that affects how well doxycycline works: calcium interferes with absorption. You should take doxycycline at least two hours before or three hours after consuming dairy products, calcium supplements, or antacids containing calcium or magnesium. Iron supplements and bismuth subsalicylate (the active ingredient in Pepto-Bismol) can also reduce absorption. Taking it with a full glass of water and staying upright for at least 30 minutes afterward helps prevent the esophageal irritation that some people experience.